Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition

Tobias Pischon, Heiner Boeing, Steffen Weikert, Naomi Allen, Tim Key, Nina Føns Johnsen, Anne Tjønneland, Marianne Tang Severinsen, Kim Overvad, Sabine Rohrmann, Rudolf Kaaks, Antonia Trichopoulou, Gitaki Zoi, Dimitrios Trichopoulos, Valeria Pala, Domenico Palli, Rosario Tumino, Carlotta Sacerdote, H. Bas Bueno-de-Mesquita, Anne MayJonas Manjer, Peter Wallström, Pär Stattin, Göran Hallmans, Genevieve Buckland, Nerea Larrañaga, María Dolores Chirlaque, Carmen Martínez, María L. Redondo Cornejo, Eva Ardanaz, Sheila Bingham, Kay Tee Khaw, Sabina Rinaldi, Nadia Slimani, Mazda Jenab, Elio Riboli

Research output: Contribution to journalArticle

Abstract

Background: Body size has been hypothesized to influence the risk of prostate cancer; however, most epidemiologic studies have relied on body mass index (BMI) to assess adiposity, whereas only a few studies have examined whether body fat distribution predicts prostate cancer. Methods: We examined the association of height, BMI, waist and hip circumference, andwaist-hip ratio with prostate cancer risk among 129,502 men without cancer at baseline from 8 countries of the European Prospective Investigation into Cancer and Nutrition (EPIC), using Cox regression, with age as time metric, stratifying by study center and age at recruitment, and adjusting for education, smoking status, alcohol consumption, and physical activity. Results: During a mean follow-up of 8.5 years, 2,446 men developed prostate cancer. Waist circumference and waist-hip ratio were positively associated with risk of advanced disease. The relative risk of advanced prostate cancer was 1.06 (95% confidence interval, 1.01-1.1) per 5-cm-higher waist circumference and 1.21 (95% confidence interval, 1.04-1.39) per 0.1-unit-higher waist-hip ratio. When stratified by BMI, waist circumference and waist-hip ratio were positively related to risk of total, advanced, and high-grade prostate cancer among men with lower but not among those with higher BMI (Pinteraction for waist with BMI, 0.25, 0.02, and 0.05, respectively; Pinteraction for waist-hip ratio with BMI, 0.27, 0.22, and 0.14; respectively). Conclusions: These data suggest that abdominal adiposity may be associated with an increased risk of advanced prostate cancer. This association may be stronger among individuals with lower BMI; however, this finding needs confirmation in future studies.

Original languageEnglish
Pages (from-to)3252-3261
Number of pages10
JournalCancer Epidemiology Biomarkers and Prevention
Volume17
Issue number11
DOIs
Publication statusPublished - Nov 2008

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Fingerprint Dive into the research topics of 'Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition'. Together they form a unique fingerprint.

  • Cite this

    Pischon, T., Boeing, H., Weikert, S., Allen, N., Key, T., Johnsen, N. F., Tjønneland, A., Severinsen, M. T., Overvad, K., Rohrmann, S., Kaaks, R., Trichopoulou, A., Zoi, G., Trichopoulos, D., Pala, V., Palli, D., Tumino, R., Sacerdote, C., Bueno-de-Mesquita, H. B., ... Riboli, E. (2008). Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiology Biomarkers and Prevention, 17(11), 3252-3261. https://doi.org/10.1158/1055-9965.EPI-08-0609